Cancer stem cells in multiple myeloma

Lapidot, 1994, A cell initiating human acute myeloid leukaemia after transplantation into SCID mice, Nature, 367, 645, 10.1038/367645a0 Al Hajj, 2003, Prospective identification of tumorigenic breast cancer cells, Proc. Natl. Acad. Sci. USA, 100, 3983, 10.1073/pnas.0530291100 Zucchi, 2007, The properties of a mammary gland cancer stem cell, Proc. Natl. Acad. Sci. USA, 104, 10476, 10.1073/pnas.0703071104 Singh, 2004, Identification of human brain tumour initiating cells, Nature, 432, 396, 10.1038/nature03128 Dalerba, 2007, Phenotypic characterization of human colorectal cancer stem cells, Proc. Natl. Acad. Sci. USA, 104, 10158, 10.1073/pnas.0703478104 O’Brien, 2007, A human colon cancer cell capable of initiating tumour growth in immunodeficient mice, Nature, 445, 106, 10.1038/nature05372 Drewinko, 1981, The growth fraction of human myeloma cells, Blood, 57, 333, 10.1182/blood.V57.2.333.333 Bergsagel, 1968, Growth characteristics of a mouse plasma cell tumor, Cancer Res., 28, 2187 TILL, 1961, A direct measurement of the radiation sensitivity of normal mouse bone marrow cells, Radiat. Res., 14, 213, 10.2307/3570892 Park, 1971, Mouse myeloma tumor stem cells: a primary cell culture assay, J. Natl. Cancer Inst., 46, 411 Hamburger, 1977, Primary bioassay of human tumor stem cells, Science, 197, 461, 10.1126/science.560061 Hamburger, 1977, Primary bioassay of human myeloma stem cells, J. Clin. Invest., 60, 846, 10.1172/JCI108839 Mellstedt, 1974, Monoclonal lymphocyte population in human plasma cell myeloma, Clin. Exp. Immunol., 17, 371 Billadeau, 1993, The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell, J. Exp. Med., 178, 1023, 10.1084/jem.178.3.1023 Bakkus, 1994, Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell, Br. J. Haematol., 87, 68, 10.1111/j.1365-2141.1994.tb04872.x Bergsagel, 1995, In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain, Blood, 85, 436, 10.1182/blood.V85.2.436.436 Chen, 1996, Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells, Blood, 87, 1972, 10.1182/blood.V87.5.1972.1972 Szczepek, 1998, A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction, Blood, 92, 2844, 10.1182/blood.V92.8.2844 Rasmussen, 1999, High numbers of clonal CD19+ cells in the peripheral blood of a patient with multiple myeloma, Br. J. Haematol., 105, 265 Pilarski, 2000, In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease, Clin. Cancer Res., 6, 585 Zojer, 2002, Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance, Br. J. Haematol., 117, 852, 10.1046/j.1365-2141.2002.03529.x Bergui, 1989, Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma, J. Exp. Med., 170, 613, 10.1084/jem.170.2.613 Caligaris-Cappio, 1985, Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma, J. Clin. Invest., 76, 1243, 10.1172/JCI112080 Kuppers, 1999, Cellular origin of human B-cell lymphomas, N. Engl. J. Med., 341, 1520, 10.1056/NEJM199911113412007 Bakkus, 1992, Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation, Blood, 80, 2326, 10.1182/blood.V80.9.2326.2326 Sahota, 1994, Assessment of the role of clonogenic B lymphocytes in the pathogenesis of multiple myeloma, Leukemia, 8, 1285 Vescio, 1995, Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity, J. Immunol., 155, 2487, 10.4049/jimmunol.155.5.2487 Rasmussen, 2000, The clonal hierarchy in multiple myeloma, Acta Oncol., 39, 765, 10.1080/028418600750063479 Rasmussen, 2004, In multiple myeloma clonotypic, Leuk. Lymphoma, 45, 1413, 10.1080/10428190410001655157 Yaccoby, 1998, Primary myeloma cells growing in SCID-hu mice. A model for studying the biology and treatment of myeloma and its manifestations, Blood, 92, 2908, 10.1182/blood.V92.8.2908 Yaccoby, 1999, The proliferative potential of myeloma plasma cells manifest in the SCID-hu host, Blood, 94, 3576, 10.1182/blood.V94.10.3576.422k01_3576_3582 Pilarski, 2000, Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice, Blood, 95, 1056, 10.1182/blood.V95.3.1056.003k26_1056_1065 Pilarski, 2002, Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice, Exp. Hematol., 30, 221, 10.1016/S0301-472X(01)00788-3 Matsui, 2004, Characterization of clonogenic multiple myeloma cells, Blood, 103, 2332, 10.1182/blood-2003-09-3064 Luckey, 2006, Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells, Proc. Natl. Acad. Sci. USA, 103, 3304, 10.1073/pnas.0511137103 Tomayko, 2008, Systematic comparison of gene expression between murine memory and naive B cells demonstrates that memory B cells have unique signaling capabilities, J. Immunol., 181, 27, 10.4049/jimmunol.181.1.27 Chang, 2007, Asymmetric T lymphocyte division in the initiation of adaptive immune responses, Science, 315, 1687, 10.1126/science.1139393 Schittek, 1990, Maintenance of B-cell memory by long-lived cells generated from proliferating precursors, Nature, 346, 749, 10.1038/346749a0 Decker, 1995, Defining subsets of naive and memory B cells based on the ability of their progeny to somatically mutate in vitro, Immunity, 2, 195, 10.1016/S1074-7613(95)80092-1 Heyzer-Williams, 2000, Antigen-specific B cell memory: expression and replenishment of a novel B220-memory B cell compartment, J. Exp. Med., 191, 1149, 10.1084/jem.191.7.1149 Aviszus, 2007, Silent development of memory progenitor B cells, J. Immunol., 179, 5181, 10.4049/jimmunol.179.8.5181 Bonnet, 1997, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nat. Med., 3, 730, 10.1038/nm0797-730 Hemmati, 2003, Cancerous stem cells can arise from pediatric brain tumors, Proc. Natl. Acad. Sci. USA, 100, 15178, 10.1073/pnas.2036535100 Matsui, 2008, Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance, Cancer Res., 68, 190, 10.1158/0008-5472.CAN-07-3096 Agematsu, 2000, CD27: a memory B-cell marker, Immunol. Today, 21, 204, 10.1016/S0167-5699(00)01605-4 Shmelkov, 2003, CD133 expression is not restricted to stem cells, and both CD133 and CD133 metastatic colon cancer cells initiate tumors, J. Clin. Invest., 12, 1 Li, 2007, Identification of pancreatic cancer stem cells, Cancer Res., 67, 1030, 10.1158/0008-5472.CAN-06-2030 Hermann, 2007, Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer, Cell Stem Cell, 1, 313, 10.1016/j.stem.2007.06.002 Namikawa, 1993, Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice, Blood, 82, 2526, 10.1182/blood.V82.8.2526.2526 Kyle, 2004, Multiple myeloma, N. Engl. J. Med., 351, 1860, 10.1056/NEJMra041875 Pilarski, 1994, Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma, Blood, 83, 724, 10.1182/blood.V83.3.724.724 Kiel, 1999, Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation, Bone Marrow Transpl., 23, 1019, 10.1038/sj.bmt.1701767 Rottenburger, 1999, Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantation, Br. J. Haematol., 106, 545, 10.1046/j.1365-2141.1999.01548.x Rasmussen, 2000, Frequency and kinetics of polyclonal and clonal B cells in the peripheral blood of patients being treated for multiple myeloma, Blood, 96, 4357, 10.1182/blood.V96.13.4357 Pilarski, 1997, Deficient drug transporter function of bone marrow-localized and leukemic plasma cells in multiple myeloma, Blood, 90, 3751, 10.1182/blood.V90.9.3751 Goodell, 2002, Multipotential stem cells and ‘side population’ cells, Cytotherapy, 4, 507, 10.1080/146532402761624638 Kastan, 1990, Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells, Blood, 75, 1947, 10.1182/blood.V75.10.1947.1947 Lobo, 2007, The biology of cancer stem cells, Annu. Rev. Cell Dev. Biol., 23, 675, 10.1146/annurev.cellbio.22.010305.104154 Taipale, 2001, The hedgehog and Wnt signalling pathways in cancer, Nature, 411, 349, 10.1038/35077219 Reya, 2001, Stem cells, cancer, and cancer stem cells, Nature, 414, 105, 10.1038/35102167 Peacock, 2007, Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma, Proc. Natl. Acad. Sci. USA, 104, 4048, 10.1073/pnas.0611682104 Coiffier, 2002, CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma, N. Engl. J. Med., 346, 235, 10.1056/NEJMoa011795 Schulz, 2007, Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis, J. Natl. Cancer Inst., 99, 706, 10.1093/jnci/djk152 Treon, 2002, CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications, J. Immunother., 25, 72, 10.1097/00002371-200201000-00008 Bensinger, 1999, Allogeneic hematopoietic cell transplantation for multiple myeloma, 887 Huff, 2003, Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cells, Biol. Blood Marrow Transpl., 9, 312, 10.1016/S1083-8791(03)00075-2 Rasmussen, 2003, Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells, Blood, 101, 4607, 10.1182/blood-2002-06-1925 Lim, 1999, Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma, Int. J. Cancer, 83, 215, 10.1002/(SICI)1097-0215(19991008)83:2<215::AID-IJC12>3.0.CO;2-Q Reichardt, 2003, Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells, Haematologica, 88, 1139 Bendandi, 2006, Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation, Leuk. Lymphoma, 47, 29, 10.1080/10428190500272473 Curti, 2007, Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides, Br. J. Haematol., 139, 415, 10.1111/j.1365-2141.2007.06832.x Spisek, 2007, Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy, J. Exp. Med., 204, 831, 10.1084/jem.20062387 Noonan, 2005, Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors, Cancer Res., 65, 2026, 10.1158/0008-5472.CAN-04-3337 Jamieson, 2004, Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML, N. Engl. J. Med., 351, 657, 10.1056/NEJMoa040258 Krivtsov, 2006, Transformation from committed progenitor to leukaemia stem cell initiated by MLLGÇôAF9, Nature, 442, 818, 10.1038/nature04980 Liu, 2008, BRCA1 regulates human mammary stem/progenitor cell fate, Proc. Natl. Acad. Sci., 105, 1680, 10.1073/pnas.0711613105 Barabe, 2007, Modeling the initiation and progression of human acute leukemia in mice, Science, 316, 600, 10.1126/science.1139851 Scadden, 2006, The stem-cell niche as an entity of action, Nature, 441, 1075, 10.1038/nature04957 Kelly, 2007, Tumor growth need not be driven by rare cancer stem cells, Science, 317, 337, 10.1126/science.1142596 Hideshima, 2002, Molecular mechanisms of novel therapeutic approaches for multiple myeloma, Nat. Rev. Cancer, 2, 927, 10.1038/nrc952 Fonseca, 2003, Clinical and biologic implications of recurrent genomic aberrations in myeloma, Blood, 101, 4569, 10.1182/blood-2002-10-3017 Zhan, 2006, The molecular classification of multiple myeloma, Blood, 108, 2020, 10.1182/blood-2005-11-013458 Hanamura, 2006, Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation, Blood, 108, 1724, 10.1182/blood-2006-03-009910